Literature DB >> 7762531

A placebo-controlled parallel study of the effect of two types of coffee oil on serum lipids and transaminases: identification of chemical substances involved in the cholesterol-raising effect of coffee.

J van Rooij1, G H van der Stegen, R C Schoemaker, C Kroon, J Burggraaf, L Hollaar, T F Vroon, A H Smelt, A F Cohen.   

Abstract

In a randomized double-blind parallel study in 36 subjects the effect on serum cholesterol of a daily dose of 2 g lipid extracted from green Arabica and Robusta coffee beans was studied. Arabica oil elevated serum total cholesterol by 1.1 mmol/L (95% CI for the difference from placebo: 0.41, 1.73 mmol/L); the effect of robusta oil (+0.5 mmol/L) was not statistically significant (95% CI: -0.01, 0.92 mmol/L). Arabica oil also raised plasma triglycerides by 0.8 mmol/L (95% CI: 0.26, 1.25 mmol/L). The effect of robusta oil on triglycerides was +0.14 mmol/L and not significant (95% CI: -0.26, 0.42 mmol/L). In the 12 subjects taking arabica oil an average serum alanine amino-transferase elevation of 18 U/L (95% CI: 9.4, 28.4 U/L) was observed. Because only arabica oil contains kahweol and arabica coffee contains more cafestol than does robusta oil, this is further evidence for the role of diterpenes in the rise of serum cholesterol and alanine aminotransferase after consumption of boiled coffee.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762531     DOI: 10.1093/ajcn/61.6.1277

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers - results of German National Health Surveys from 1984 to 1999.

Authors:  Yong Du; Hans-Ulrich Melchert; Hildtraud Knopf; Marianne Braemer-Hauth; Barbara Gerding; Ellen Pabel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Comparison of effect of cafetière and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial.

Authors:  R Urgert; S Meyboom; M Kuilman; H Rexwinkel; M N Vissers; M Klerk; M B Katan
Journal:  BMJ       Date:  1996-11-30

Review 3.  The effect of green coffee extract supplementation on cardio metabolic risk factors: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Mehrnaz Morvaridi; Elham Rayyani; Malihe Jaafari; Alireza Khiabani; Mehran Rahimlou
Journal:  J Diabetes Metab Disord       Date:  2020-05-15

Review 4.  The cholesterol-raising factor from coffee beans.

Authors:  R Urgert; M B Katan
Journal:  J R Soc Med       Date:  1996-11       Impact factor: 18.000

5.  Efficacy of Arabica Versus Robusta Coffee in Improving Weight, Insulin Resistance, and Liver Steatosis in a Rat Model of Type-2 Diabetes.

Authors:  Pedram Shokouh; Per B Jeppesen; Christine B Christiansen; Fredrik B Mellbye; Kjeld Hermansen; Søren Gregersen
Journal:  Nutrients       Date:  2019-09-03       Impact factor: 5.717

6.  Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan.

Authors:  Hidenobu Takami; Mariko Nakamoto; Hirokazu Uemura; Sakurako Katsuura; Miwa Yamaguchi; Mineyoshi Hiyoshi; Fusakazu Sawachika; Tomoya Juta; Kokichi Arisawa
Journal:  J Epidemiol       Date:  2012-10-06       Impact factor: 3.211

7.  Coffee bean extracts rich and poor in kahweol both give rise to elevation of liver enzymes in healthy volunteers.

Authors:  Mark V Boekschoten; Evert G Schouten; Martijn B Katan
Journal:  Nutr J       Date:  2004-07-15       Impact factor: 3.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.